Tipo de artículo
Condición
Encuadernación
Más atributos
Gastos de envío gratis
Ubicación del vendedor
Valoración de los vendedores
Publicado por Fondationj Nationale De Transfusion Sanguine, Les Uli, 1990
Librería: Walk A Crooked Mile Books, Williamsburg, PA, Estados Unidos de America
Soft cover. Condición: Fine. Estado de la sobrecubierta: No Dust Jacket. SCI 018237 LIVEZEY Good as new soft cover, in English.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.
Publicado por MDPI AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
Libro Impresión bajo demanda
HRD. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Publicado por Mdpi AG 11/29/2023, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: BargainBookStores, Grand Rapids, MI, Estados Unidos de America
Libro
Hardback or Cased Book. Condición: New. Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer 1.37. Book.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: As New. Unread book in perfect condition.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: California Books, Miami, FL, Estados Unidos de America
Libro
Condición: New.
Publicado por MDPI AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: New.
Publicado por LAP LAMBERT Academic Publishing Dez 2017, 2017
ISBN 10: 6202198184ISBN 13: 9786202198189
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Immunotherapy as a therapeutic option for cancer therapy has contributed immensely to the success gained so far in the fight against cancer. Notwithstanding, the use of immunotherapy is not a common practice in most health facilities that handle cancer cases, and can be attributed to the fact that these immunotherapeutic agents are usually expensive compared to alternative options. This book therefore discusses the possible formats used in developing immunotherapeutic agents. Introduction and the first three chapters introduce the reader to the general concept of cancer and the various forms of cancer. The common therapeutic options and their respective therapeutic agents are also covered under these chapters. This is necessary to equip novices with basic knowledge about cancer and bring them to an appreciable level of understanding with respect to the concept of immunotherapy. Chapter four explains the various formats for developing immunotherapeutic agents as well as applications of these agents. This book will diffuse the perception that developing immunotherapeutic agent is a herculean task if not impossible, and also whip up your interest immunotherapy. 184 pp. Englisch.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: As New. Unread book in perfect condition.
Publicado por MDPI AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
Libro Impresión bajo demanda
HRD. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: GF Books, Inc., Hawthorne, CA, Estados Unidos de America
Libro
Condición: New. Book is in NEW condition. 1.37.
Publicado por Mdpi AG, 2023
ISBN 10: 303659566XISBN 13: 9783036595665
Librería: Books Unplugged, Amherst, NY, Estados Unidos de America
Libro
Condición: Good. Buy with confidence! Book is in good condition with minor wear to the pages, binding, and minor marks within 1.37.
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 6202198184ISBN 13: 9786202198189
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Immunotherapy as a therapeutic option for cancer therapy has contributed immensely to the success gained so far in the fight against cancer. Notwithstanding, the use of immunotherapy is not a common practice in most health facilities that handle cancer cases, and can be attributed to the fact that these immunotherapeutic agents are usually expensive compared to alternative options. This book therefore discusses the possible formats used in developing immunotherapeutic agents. Introduction and the first three chapters introduce the reader to the general concept of cancer and the various forms of cancer. The common therapeutic options and their respective therapeutic agents are also covered under these chapters. This is necessary to equip novices with basic knowledge about cancer and bring them to an appreciable level of understanding with respect to the concept of immunotherapy. Chapter four explains the various formats for developing immunotherapeutic agents as well as applications of these agents. This book will diffuse the perception that developing immunotherapeutic agent is a herculean task if not impossible, and also whip up your interest immunotherapy.
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 6202198184ISBN 13: 9786202198189
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Omane Acheampong DesmondDr. Desmond Omane Acheampong is a Senior Lecturer and Head of the Department of Biomedical Sciences, University of Cape Coast. He holds a PhD in Microbiological and Biochemical Pharmacy and MSc in Clinical Mic.
Publicado por Springer, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Soft Cover. Condición: new.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Hardcover. Condición: new.
Publicado por Springer Berlin Heidelberg Dez 2014, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 392 pp. Englisch.
Publicado por Springer, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents the recent advances in antibody engineering and in the various clinical applicationsAn invaluable resource for both experts and those new to the fieldWith contributions by international experts from research and biotech companies.
Publicado por Springer Berlin Heidelberg, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents the recent advances in antibody engineering and in the various clinical applicationsAn invaluable resource for both experts and those new to the fieldWith contributions by international experts from research and biotech companies.
Publicado por Springer, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer Berlin Heidelberg Jul 2011, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro
Buch. Condición: Neu. Neuware -The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 392 pp. Englisch.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: New.
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.
Publicado por Springer Berlin Heidelberg, 2014
ISBN 10: 3642432077ISBN 13: 9783642432071
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.
Publicado por Springer, 2011
ISBN 10: 3642209092ISBN 13: 9783642209093
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: As New. Unread book in perfect condition.